Recombinant Zoster Vaccine Significantly Reduces the Impact on Quality of Life Caused by Herpes Zoster in Adult Autologous Hematopoietic Stem Cell Transplant Recipients: A Randomized Placebo-Controlled Trial (ZOE-HSCT)-Reference-Cited by-同舟云学术

Recombinant Zoster Vaccine Significantly Reduces the Impact on Quality of Life Caused by Herpes Zoster in Adult Autologous Hematopoietic Stem Cell Transplant Recipients: A Randomized Placebo-Controlled Trial (ZOE-HSCT)

Published:2019-12 Issue:12 Volume:25 Page:2474-2481
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Curran Desmond,Matthews Sean^ORCID,Rowley Scott D.,Young Jo-Anne H.,Bastidas Adriana,Anagnostopoulos Achilles^ORCID,Barista Ibrahim,Chandrasekar Pranatharthi Haran,Dickinson Michael^ORCID,El Idrissi Mohamed,Heras Inmaculada,Milliken Samuel T.^ORCID,Monserrat Coll Jorge,Navarro Matilla María Belén,Oostvogels Lidia,Piątkowska-Jakubas Beata,Quiel Dimas,Sabry Waleed^ORCID,Schwartz Stefan^ORCID,Selleslag Dominik L.D.,Sullivan Keith M.,Theunissen Koen,Yegin Zeynep Arzu,Yeh Su-Peng,Zaja Francesco,Szer Jeff

Funder

GlaxoSmithKline

Basilea Pharmaceutica

Pharmaceuticals

Pfizer

Sanofi

Genzyme

Shire

Publisher

Elsevier BV

Subject

Transplantation,Hematology